MX8958A - Procedimiento para obtener un preparado liofilizado que contiene ifosfamida. - Google Patents
Procedimiento para obtener un preparado liofilizado que contiene ifosfamida.Info
- Publication number
- MX8958A MX8958A MX895887A MX895887A MX8958A MX 8958 A MX8958 A MX 8958A MX 895887 A MX895887 A MX 895887A MX 895887 A MX895887 A MX 895887A MX 8958 A MX8958 A MX 8958A
- Authority
- MX
- Mexico
- Prior art keywords
- procedure
- obtaining
- lyophilized preparation
- preparation containing
- ifosfamide
- Prior art date
Links
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001101 ifosfamide Drugs 0.000 title abstract 3
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Control Of El Displays (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Amplifiers (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3637089 | 1986-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX8958A true MX8958A (es) | 1993-12-01 |
Family
ID=6312873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX895887A MX8958A (es) | 1986-10-31 | 1987-10-23 | Procedimiento para obtener un preparado liofilizado que contiene ifosfamida. |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0265812B1 (forum.php) |
| JP (1) | JPS63159319A (forum.php) |
| KR (1) | KR900003491B1 (forum.php) |
| AT (1) | ATE55250T1 (forum.php) |
| AU (1) | AU598602B2 (forum.php) |
| CA (1) | CA1314231C (forum.php) |
| DD (1) | DD262582A5 (forum.php) |
| DE (1) | DE3764235D1 (forum.php) |
| DK (1) | DK169308B1 (forum.php) |
| EG (1) | EG18333A (forum.php) |
| ES (1) | ES2017982B3 (forum.php) |
| FI (1) | FI87140C (forum.php) |
| GE (1) | GEP19971025B (forum.php) |
| GR (1) | GR3000708T3 (forum.php) |
| HU (1) | HU197987B (forum.php) |
| IL (1) | IL84312A (forum.php) |
| IN (1) | IN168119B (forum.php) |
| LV (1) | LV10051B (forum.php) |
| MX (1) | MX8958A (forum.php) |
| NO (1) | NO873860L (forum.php) |
| PT (1) | PT86032B (forum.php) |
| RU (1) | RU1836079C (forum.php) |
| UA (1) | UA11075A (forum.php) |
| YU (1) | YU197387A (forum.php) |
| ZA (1) | ZA878183B (forum.php) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE58900183D1 (de) * | 1988-03-19 | 1991-08-29 | Asta Pharma Ag | Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung. |
| US5227373A (en) * | 1991-10-23 | 1993-07-13 | Bristol-Myers Squibb Co. | Lyophilized ifosfamide compositions |
| WO1995007083A1 (en) * | 1993-09-10 | 1995-03-16 | F.H. Faulding & Co. Limited | Ifosfamide lyophilisate composition |
| DE19529057B4 (de) * | 1995-08-08 | 2007-12-13 | Baxter Healthcare S.A. | Ifosfamid-Lyophilisat-Zubereitungen |
| EP1058547B1 (en) * | 1998-03-03 | 2005-11-23 | Shionogi & Co., Ltd. | Pharmaceutical compositions containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
| EA008776B1 (ru) * | 2002-09-05 | 2007-08-31 | Бхарат Сирумс Энд Вэксинс Лтд. | Жидкая стабильная композиция оксазафосфорина с месной |
| BR0316968A (pt) * | 2002-12-02 | 2005-10-25 | Bharat Serums & Vaccines Ltd | Composições estáveis, claras, aquosas de ifosfamida para administração parenteral que apresentam pouca toxicidade; processo para a preparação de composições de ifosfamida; e composições de ifosfamida e um processo para a preparação das mesmas |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| BRPI0715279A2 (pt) * | 2006-09-29 | 2013-06-11 | Infa Sa | sistema de embalagem, sistema de embalagem para uma composiÇço farmacÊutica, mÉtodo para transferir uma composiÇço farmcÊutica para administraÇço por infusço intravenosa, uso de um sistema de embalagem, kit para administraÇço parenteral de fÁrmacos com um acesso intravenoso e kit admnistraÇço parenteral de princÍpios ativos |
| CN105900385B (zh) * | 2014-12-04 | 2019-08-27 | 华为技术有限公司 | 在数据通信网中的负载分配 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3732340A (en) * | 1966-07-11 | 1973-05-08 | Asta Werke Ag Chem Fab | N',o-propylene phosphoric acid ester diamides |
| DE2750207A1 (de) * | 1977-05-09 | 1978-11-16 | Walton J Smith | Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung |
| DE3279834D1 (en) * | 1981-12-31 | 1989-08-31 | Asta Pharma Ag | 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression |
| US4537883A (en) * | 1982-11-12 | 1985-08-27 | Mead Johnson & Company | Lyophilized cyclophosphamide |
-
1987
- 1987-09-15 NO NO873860A patent/NO873860L/no unknown
- 1987-10-20 EP EP87115322A patent/EP0265812B1/de not_active Expired - Lifetime
- 1987-10-20 DE DE8787115322T patent/DE3764235D1/de not_active Expired - Lifetime
- 1987-10-20 ES ES87115322T patent/ES2017982B3/es not_active Expired - Lifetime
- 1987-10-20 AT AT87115322T patent/ATE55250T1/de not_active IP Right Cessation
- 1987-10-23 MX MX895887A patent/MX8958A/es unknown
- 1987-10-26 IN IN837/CAL/87A patent/IN168119B/en unknown
- 1987-10-27 FI FI874727A patent/FI87140C/fi not_active IP Right Cessation
- 1987-10-28 EG EG61687A patent/EG18333A/xx active
- 1987-10-29 RU SU874203570A patent/RU1836079C/ru active
- 1987-10-29 JP JP62272002A patent/JPS63159319A/ja active Granted
- 1987-10-29 UA UA4203570A patent/UA11075A/uk unknown
- 1987-10-29 PT PT86032A patent/PT86032B/pt unknown
- 1987-10-29 IL IL84312A patent/IL84312A/xx not_active IP Right Cessation
- 1987-10-30 AU AU80529/87A patent/AU598602B2/en not_active Ceased
- 1987-10-30 HU HU874900A patent/HU197987B/hu unknown
- 1987-10-30 ZA ZA878183A patent/ZA878183B/xx unknown
- 1987-10-30 DK DK569687A patent/DK169308B1/da not_active IP Right Cessation
- 1987-10-30 CA CA000550706A patent/CA1314231C/en not_active Expired - Lifetime
- 1987-10-30 KR KR1019870012077A patent/KR900003491B1/ko not_active Expired
- 1987-10-30 DD DD87308471A patent/DD262582A5/de not_active IP Right Cessation
- 1987-10-30 YU YU01973/87A patent/YU197387A/xx unknown
-
1990
- 1990-08-09 GR GR90400533T patent/GR3000708T3/el unknown
-
1992
- 1992-10-27 LV LVP-92-174A patent/LV10051B/lv unknown
-
1993
- 1993-07-07 GE GEAP1993972A patent/GEP19971025B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0427247A3 (en) | Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient | |
| PT90030A (pt) | Processo para a preparacao de liofilisado de ifosfamida e mesna | |
| ES541413A0 (es) | Un procedimiento para preparar polimeros o copolimeros que contienen al menos 25% en peso de grupos de m-alquilo. | |
| SE8603582D0 (sv) | Komposition innehallande l-dopa | |
| MX8958A (es) | Procedimiento para obtener un preparado liofilizado que contiene ifosfamida. | |
| IT8547683A0 (it) | Procedimento per la preparazione dicomposti 1,3-diossolan-4-metanolici otticamente attivi | |
| EP0271013A3 (en) | Basic substituted phenyl acetonitriles, their preparation and medicaments containing them | |
| DK23490A (da) | Implanteret antibiotisk tilberedning med reguleret frigivelse | |
| NO883520D0 (no) | Fremgangsmaate for fremstilling av et injeksjonspreparat. | |
| BG90414A (bg) | 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им | |
| ES2064652T3 (es) | Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato. | |
| ATA279787A (de) | Verwendung eines oestradiolderivates zur herstellung eines pharmazeutischen praeparates zur unterdrueckung der immunreaktion | |
| ZA875676B (en) | The use of 15-deoxyspergualine as a pharmaceutical | |
| MX5413A (es) | Procedimiento para la preparacion de n-benzoil-n'-fenilureas. | |
| RO105809B1 (ro) | PROCEDEU PENTRU PREPARAREA bis-N,N'-(DIMETILFORMAMIDO) | |
| ATE75613T1 (de) | 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen. | |
| ES541806A0 (es) | Un procedimiento para la preparacion de un derivado de 1,4: 3,6-dianhidrohexitol | |
| IT8842522A0 (it) | Procedimento per la preparazione di 2 - (2,4 diclorofenil)metil4 - (1,1, 3,3 tetrametilbutil)fenolo (clofoctolo) | |
| IT8024682A0 (it) | Procedimento per la preparazione dell'amiodarone. | |
| ES544510A0 (es) | Procedimiento para la preparacion de un derivado de 1,4-di- hidropiridina |